Article
Author(s):
Top news of the day from across the health care landscape.
Recent data suggest that short sleep duration may be associated with the male gender, older age, low social status, and high coffee intake, according to The American Journal of Managed Care. The study involved a cross-sectional analysis of 82,995 participants in the UK Biobank cohort, from which researchers collected sociodemographic and lifestyle data through the use of touch-screen questionnaires from 2007 to 2010. The researchers concluded that male gender, older age, low social status, and high coffee intake is associated with objectively determined short sleep duration.
A new report from the World Health Organization (WHO) suggests that cases of cholera, an acute diarrheal disease, are on the decline, according to Contagion Live. The new report indicates that the global incidence of cholera cases decreased by 60% in 2018. In total, there were 499,447 cases of the disease with 2990 associated deaths documented in 2018, as per reports from 34 countries. In 2019, nearly 18 million doses of oral cholera vaccines were shipped to 11 countries. Currently, there are 3 WHO prequalified oral cholera vaccines: Dukoral, Sanchol, and Euvichol-plus.
A combination of reduced-harm, non-cigarette nicotine products could provide a small improvement to a person’s smoking cessation efforts, according to MD Magazine. The pragmatic, 3-arm, parallel trial included adult smokers who were naïve to e-cigarettes and who were motivated to quit smoking. When examining continuous abstinence from smoking, nicotine patches plus nicotine e-cigarettes were confirmed to be associated with long-term smoking cessation in 3 to 7 more smokers per 100 than alternative methods.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa